Connect
MJA
MJA

Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners

Mark R Nelson
Med J Aust 2004; 180 (3): . || doi: 10.5694/j.1326-5377.2004.tb05841.x
Published online: 2 February 2004

Mark R Nelson


  • Department of Epidemiology and Preventive Medicine, Monash University, Commercial Road, Prahran, VIC 3181.



  • 1. Kerr SJ, Mant A, Horn FE, et al. Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners. Med J Aust 2003; 179: 403-407. <eMJA full text> <MJA full text>
  • 2. Nelson MR, Reid CM, Krum H, McNeil JJ. Factors influencing family physician adherence to hypertension treatment guideline recommendations on the initiation of pharmacotherapy. Am J Cardiovasc Drugs. In press.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.